Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2009-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S1353-8020(09)70807-7PMID 20082982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders.

  2009cited by this paper
• Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys

  2009cited by this paper
• Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies.

  2009cited by this paper
• The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.

  2009cited by this paper
• Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior.

  2009cited by this paper
• Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.

  2009cited by this paper
• Optical Deconstruction of Parkinsonian Neural Circuitry

  2009cited by this paper
• Lesion of the centromedian thalamic nucleus in MPTP‐treated monkeys

  2008cited by this paper
• Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?

  2008cited by this paper
• High-Frequency Stimulation of the Subthalamic Nucleus Potentiates l-DOPA-Induced Neurochemical Changes in the Striatum in a Rat Model of Parkinson's Disease

  2007cited by this paper
• Bilateral Implantation of Centromedian‐Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease

  2006cited by this paper
• Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission

  2006cited by this paper
• Subthalamic Stimulation-Induced Forelimb Dyskinesias Are Linked to an Increase in Glutamate Levels in the Substantia Nigra Pars Reticulata

  2006cited by this paper
• Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats

  2006cited by this paper
• The Role of the Parafascicular Complex (CM-Pf) of the Human Thalamus in the Neuronal Mechanisms of Selective Attention

  2006cited by this paper
• The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.

  2005cited by this paper
• Intralaminar Thalamic Nuclei Lesions: Widespread Impact on Dopamine Denervation‐Mediated Cellular Defects in the Rat Basal Ganglia

  2004cited by this paper
• The thalamostriatal system: a highly specific network of the basal ganglia circuitry.

  2004cited by this paper
• Center Median-Parafascicular Complex and Pain Control

  2004cited by this paper
• Nigral and pallidal inputs to functionally segregated thalamostriatal neurons in the centromedian/parafascicular intralaminar nuclear complex in monkey

  2002cited by this paper
• Deep brain stimulation of the centre median-parafascicular complex in patients with movement disorders

  2002cited by this paper
• High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the Rat

  2002cited by this paper
• The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness.

  2002cited by this paper
• Neurons in the thalamic CM-Pf complex supply striatal neurons with information about behaviorally significant sensory events.

  2001cited by this paper
• Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.

  2000cited by this paper
• Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.

  2000cited by this paper
• Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex

  1999cited by this paper
• Systemic administration of MPTP induces thalamic neuronal degeneration in mice.

  1997cited by this paper
• Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic.

  1993cited by this paper
• Parafascicular-center median nuclei stimulation for intractable pain and dyskinesia (painful-dyskinesia).

  1980cited by this paper
• Lesions of the centrum medianum in the treatment of movement disorders.

  1965cited by this paper

• The parafascicular nucleus of the thalamus orchestrates coordinated skeletomotor, autonomic, and aversive state transitions

  2026cites this paper
• The intralaminar thalamus: a review of its role as a target in functional neurosurgery

  2023cites this paper
• New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review

  2022influential citation
• Processing of information from the parafascicular nucleus of the thalamus through the basal ganglia

  2022cites this paper
• Thalamic projections to the subthalamic nucleus contribute to movement initiation and rescue of parkinsonian symptoms

  2021cites this paper
• Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.

  2019cites this paper
• Deep Brain Stimulation in Parkinson's Disease

  2018cites this paper
• On the neuronal circuitry mediating l-DOPA-induced dyskinesia

  2018cites this paper
• Harnessing Pallidal Cell-Type Diversity to Treat Neurological Disorders

  2017cites this paper
• Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals

  2017cites this paper
• Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson’s Disease Differently Affects Behavior

  2017cites this paper
• Deep brain stimulation improves gait velocity in Parkinson’s disease: a systematic review and meta-analysis

  2016cites this paper
• Clinical efficacy of deep brain stimulation for the treatment of medically refractory epilepsy.

  2016cites this paper
• Novel targets and stimulation paradigms for deep brain stimulation

  2015cites this paper
• The latest evidence on target selection in deep brain stimulation for Parkinson's disease.

  2014cites this paper
• Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.

  2014cites this paper
• Transgenic Mouse Lines Subdivide External Segment of the Globus Pallidus (GPe) Neurons and Reveal Distinct GPe Output Pathways

  2014cites this paper
• New targets for deep brain stimulation treatment of Parkinson’s disease

  2013cites this paper
• Surgical Treatment of Parkinson’s Disease: Patients, Targets, Devices, and Approaches

  2013cites this paper
• Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa

  2012cites this paper
• New targets for DBS.

  2012cites this paper
• Focused ultrasound modulates the level of cortical neurotransmitters: Potential as a new functional brain mapping technique

  2011cites this paper
• Núcleos intralaminares posteriores del tálamo y procesos cognitivos

  2010cites this paper
• Núcleos intralaminares posteriores del tálamo y procesos cognitivos

  2010influential citation
• Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets

  2010cites this paper